Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies
Can't see this email? View it online
   
  Rheumatology Rheumatology logo  
  The latest rheumatology news from News Medical  
 Cardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseasesCardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseases
 
A genetic connection between cardiovascular disease and psoriasis highlights shared inflammatory pathways, emphasizing the need for cardiovascular monitoring.
 
 
 Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapiesMicrobial biomarkers identified in lupus and IBD offer pathways for targeted therapies
 
Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted therapies for autoimmune disorders.
 
   Mechanically stimulated 3D multicellular systemsMechanically stimulated 3D multicellular systems
 
To study biomechanical forces in multicellular systems, effective mechanical stimulation is an essential tool. A 3D microstructure device is developed using Two-Photon Polymerization (2PP)-based 3D printing for mimicking the human multicellular environment.
 
   Researchers gain new understanding of how immune cells respond to heat during feverResearchers gain new understanding of how immune cells respond to heat during fever
 
The study reveals that moderate fever enhances CD4 T cell activity while reducing regulatory T cell suppression, highlighting temperature's immune effects.
 
   Study highlights limited evidence for antidepressants in treating pain in older adultsStudy highlights limited evidence for antidepressants in treating pain in older adults
 
University of Sydney research has found people over 65 are being prescribed antidepressants as pain treatment based on international guidelines that use limited evidence.
 
 Philanthropic investment establishes research center to advance precision diagnosis for diseases
 
Philanthropic investment establishes research center to advance precision diagnosis for diseasesAn outstanding $21 million philanthropic investment will establish a pioneering research center to advance precision diagnosis for diseases that affect millions of Australians.
 
 
 'Treating Naturally Occurring Disease’, explained by Founder, Professor Noel Fitzpatrick
 
'Treating Naturally Occurring Disease’, explained by Founder, Professor Noel FitzpatrickHumanimal Trust advocates for studying naturally occurring diseases in animals to advance cancer and osteoarthritis treatments for both humans and animals.
 
 
 Steritas' Pediatric Glucocorticoid Toxicity Index applied in clinical trial to assess steroid-toxicity
 
Steritas' Pediatric Glucocorticoid Toxicity Index applied in clinical trial to assess steroid-toxicitySteritas LLC.
 
 
 Premature ovarian insufficiency in women linked to greater risk of severe autoimmune conditions
 
Premature ovarian insufficiency in women linked to greater risk of severe autoimmune conditionsSevere autoimmune conditions such Type I diabetes, Addison's disease, lupus and inflammatory bowel disease, are between two to three times more common in women who have been diagnosed with premature ovarian insufficiency (POI) compared to the general population.
 
 
 Study highlights potential for targeting macrophages to improve rheumatoid arthritis outcomes
 
Study highlights potential for targeting macrophages to improve rheumatoid arthritis outcomesCurrently there are no cures for rheumatoid arthritis (RA) which affects 40,000 people in Ireland. The disease costs an estimated €20,000 per patient, per year with an overall cost to the health system of ~€544 million.